As filed with the Securities and Exchange Commission on February 25, 2020
RegistrationNo. 333- 220306
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORMS-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
MEDPACE HOLDINGS, INC.
(Exact name of Registrant as Specified in its Charter)
| Delaware | 5375 Medpace Way Cincinnati, Ohio 45227 (513)579-9911 | 32-0434904 | ||
(State Or Other Jurisdiction Of Incorporation Or Organization) | (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) | (IRS Employer Identification Number) |
August J. Troendle
President, Chief Executive Officer and Chairman of the Board of Directors
Jesse J. Geiger
Chief Financial Officer and Chief Operating Officer, Laboratory Operations
Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, Ohio 45227
(513)579-9911
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
F. Mark Reuter
Keating Muething & Klekamp PLL
One East Fourth Street, Suite 1400
Cincinnati, Ohio 45202
Telephone: (513)579-6469
Facsimile: (513)579-6457
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: From time to time after this registration statement becomes effective.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||
| Emerging growth company | ☐ | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment relates to the Registration Statement onForm S-3 (RegistrationNo. 333-220306) filed on September 1, 2017, pertaining to Debt Securities, Preferred Stock, Common Stock, Depositary Shares, Warrants, and Units of Medpace Holdings, Inc.
The undersigned Registrant hereby removes and withdraws from registration all securities registered pursuant to this Registration Statement which remain unissued and unsold.
On February 25, 2020 Medpace Holdings, Inc. filed a new Registration Statement onForm S-3 registering shares of Common Stock to be offered by selling shareholders as well as other securities to be offered on behalf of Medpace Holdings, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, and Rule 478 thereunder, the Registrant has duly caused this Post-Effective Amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cincinnati, Ohio, as of the 25th day of February, 2020.
| MEDPACE HOLDINGS, INC. | ||
| By: | /s/ Stephen P. Ewald | |
Stephen P. Ewald, General Counsel and Corporate Secretary | ||
No other person is required to sign this Post-Effective Amendment No. 1 to the Registration Statement in reliance upon Rule 478 of the Securities Act of 1933.
